Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07701733

A Study of Lung Cancer Risk

The researchers are doing this study to learn more about factors that may increase the risk of lung cancer in people who have never smoked. This information may help predict which people who have never smoked may be more likely to get lung cancer.

Recruiting

Interested in participating?

Request Info

Key information

Age range

40 year–74 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Criteria:

  • Female at birth
  • Age 40-74 years
  • No smoking history
  • Participants must be never-smokers, defined as having smoked <100 cigarettes in their lifetime
  • Documentation of disease - case patients

o Case patients must have pathologically confirmed primary lung adenocarcinoma. New and prevalent cases will be eligible. Case patients with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.

  • Criteria for control participants
  • Control participants must have no personal history of lung cancer, symptoms suspicious for lung cancer, or suspicious pulmonary nodules. Participants recruited as controls and found on imaging to have lesions suspicious for lung cancer will be excluded from analysis and followed prospectively. Data regarding these participants will be reported in a sensitivity analysis. Additional control participants will be recruited to ensure balanced age- and race-matched enrollment by frequency matching. Control participants with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.

Treatment and study plan

Questionnaire

Other

The study questionnaire will be administered at a regular treatment visit for case patients and at a study-specific visit for control participants. At the same visit, 1 vial of blood will be collected for genomic analysis for research purposes from both case patients and control participants. Collection of demographic information and exposure data.

Primary outcomes

  1. Identify factors associated with the risk of NSCLC

    Time frame: 3 years

    analyses will include all participants who completed the demographic and exposure assessment and whole-exome sequencing

Study contacts

Contact information is provided by the study sponsor or research team.

Alexis Chidi, MD, PhD

CONTACT

[email protected]

(929) 829-0677

Tafadzwa Chaunzwa, MD

CONTACT

(929) 829-0677

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

ARISE: Assessing Lung Cancer Risk in Never-Smoking Women

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Jul 14, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.